Today, the future of cancer treatment and the chances of survival look more promising than ever. there is a healing tree that grows deep within us and more in the Amazon rain forest in South America that could literally change how you, your doctor, and possibly the rest of the world think about curing cancer. With extracts from this powerful tree, it may now be possible to conquer cancer safely and effectively with an all-natural therapy that doesn’t cause extreme nausea, weight loss, and hair loss, protects your immune system and evade deadly infections, feel strong and healthy throughout the course of treatment, boost your energy and improve your outlook on life.
Through a series of confidential communications involving a researcher from one of America’s largest pharmaceutical companies, this ancient tree’s anticancerous properties have recently come to light. the tree has been studied in more than 20 laboratory tests since the 1970s, where it’s been shown to effectively target and kill malignant cells in 12 different types of cancer, including colon, breast, prostate, lung, and pancreatic cancer, it is 10,000 times stronger in killing colon cancer cells than Adriamycin, a commonly used chemotherapeutic drug. It selectively hunts down and kills cancer cells without harming healthy cells, unlike chemotherapy, so why isn’t every health publication extolling the benefits of this treatment? Why hasn’t it been made widely available throughout the natural-medicine community? And, if it’s only half as promising as it appears to be, why isn’t every oncologist at every major hospital insisting on using it on all his patients? Especially when you consider that since the early 1990s, extensive independent research–including research by one of today’s leading drug companies and by the National Cancer Institute–confirms that the tree’s chemical extracts attack and destroy cancer cells with lethal precision. The answer to these difficult questions can only be explained by recounting a disturbing story that was uncovered; the story of this wonderful Amazon cancer treatment reinforces, the need for groups like HSI and others to illustrate how easily our options for medical treatment are controlled by money and power. News of this amazing tree was nearly lost forever. A confidential source, an account that have been independently confirm, revealed that a billion-dollar drug company in the United States tried for nearly seven years to synthesize two of the tree’s most powerful anti cancer chemicals.
In the early 1990s, behind lock and key, this well-known drug giant began searching for a cure for cancer while preciously guarding their opportunity to patent it and, therefore, profit from it. Research focused on a legendary healing tree called Graviola. Parts of the tree–including the bark, leaves, and roots, fruit, and fruit seeds had been used for centuries by medicine men and native Indians in South America to treat heart disease, asthma, liver problems, and arthritis. Going on little documented scientific evidence, the company poured money and resources into testing Graviola’s anticancerous properties and they were shocked by the results. Graviola was a cancer-killing dynamo. But that’s where the story of Graviola nearly ended.The pharmaceutical company had a big problem. They’d spent years trying to isolate and create man-made duplicates of two of the tree’s most powerful chemicals. But they hit a brick wall. They couldn’t replicate the original. And they couldn’t sell the tree extract itself profitably because federal law mandates that natural substances can’t be patented. That meant the company couldn’t protect its profits on the project it had poured millions of dollars and nearly seven years of research into. As the dream of big profits evaporated, testing on Graviola came to a screeching halt after seven frustrating years and without the promise of lucrative sales, the company shelved the project and refused to publish its findings in an independent journal. But one responsible researcher struggled with the decision. While understanding the company’s goal of profits, he couldn’t accept the decision to hide this unique cancer killer from the world. Following his conscience and risking his career, he contacted Raintree Nutrition, a company dedicated to harvesting plants from the Amazon. As a result, Rain tree went into high gear and began to research related studies published on Graviola. They discovered that several other teams in the United States (in addition to that of the drug company) had been testing Graviola in vitro (in test tubes). The results supported the drug company’s secret findings; Graviola had been shown to kill cancer cells .Encouraged by these early laboratory tests, Raintree hired indigenous Indian tribes in Brazil to grow and harvest the tree. They spent a year on research and development and then began offering Graviola in the United States. They also developed a new supplement called N-Tense, which contains 50 percent Graviola as well as smaller amounts of seven other cancer-killing botanical extracts.Graviola hunts down and destroys prostate, lung, breast, colon, and pancreatic cancers, leaving healthy cells alone. It appears one of the first scientific references to United States was by the National Cancer Institute (NCI) in 1976. Graviola has been shown to kill cancer cells. The most recent study, conducted at Catholic University of South Korea earlier this year, revealed that two chemicals extracted from Graviola seeds showed “selective cytotoxicity comparable with Adriamycin” for breast and colon cancer cells. The chemicals targeted and killed malignant breast and colon cells. Graviola is not only comparable to Adriamycin. Graviola selectively targets cancer cells leaving healthy cells untouched. Chemotherapy indiscriminately seeks and destroys all actively reproducing cells – even normal, healthy ones. Other promising and ongoing research at Purdue University is supported by a grant from the National Cancer Institute. Purdue researchers recently found that leaves from the Graviola tree killed cancer cells “among six human-cell lines” and were especially effective against prostate and pancreatic cancer cells. In a separate study, Purdue researchers showed that extracts from the Graviola leaves are extremely effective in isolating and killing lung cancer cells. In this respect, Graviola looks to be a promising alternative or supplement to mainstream treatments.
This is the underlying challenge to substantiating most nutritional therapies. Fortunately, Graviola is a natural substance, so we don’t have to wait again for the drug companies. And, thanks to that researcher with a conscience. Raintree Nutrition bravely took the initiative in making this promising cure available. Only a relative handful of doctors and patients in the United States have been using Graviola and the Graviola-rich botanical supplement N-Tense to fight cancer. Still, according to Raintree Nutrition, the combined therapy has produced some incredible results. You can make tea out of the Graviola leaves, obtain the herb alone in capsule form, or benefit from the power of Graviola combined with seven other immune-boosting herbs. Capsules .Graviola fights more than cancer. While the research on Graviola has focused on its cancer-fighting effect, the plant has been used for centuries by medicine men in South America to treat an astonishing number of ailments, including: hypertension, ringworm, influenza, scurvy, rashes, malaria, neuralgia, dysentery, arthritis, palpitations, rheumatism, nervousness, high blood pressure, insomnia, diarrhea, fever, nausea, boils, dyspepsia, muscle spasm, ulcer, Despite the mounting collection of laboratory tests and anecdotal reports about this cancer-fighting dynamo. Graviola may just provide the help you’ve been looking for that could make all the difference in beating cancer.
Dr. Tonifelix C. Manu
(PHYTOTHERAPIST)
